Announce Date | 05/08/2024 |
EPS Normalized Actual | $0.89 (Beat by $0.4) |
EPS GAAP Actual | $0.89 (Beat by $0.4) |
Revenue Actual | $0.207659B |
Revenue Surprise | Beat by $207.659M |
Announce Date | 06/29/2024 (Pre-Market) |
EPS Normalized Estimate | $0.43429 |
EPS GAAP Estimate | $0.43429 |
Revenue Estimate | $0.317373435B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2027 | 3.33 | 15.94 | 3.26149 | 3.41996 | 0 |
Sep 2026 | 2.85 | 18.62 | 2.79137 | 2.92699 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (Apr 2022) | -0.38 | -0.38 | 0.207659B | 20.69% | 207.66M |
FQ1 2022 (Jan 2022) | -0.15 | -0.15 | 0.129223B | -0.94% | 129.22M |
FQ4 2021 (Oct 2021) | -0.09 | -0.09 | 0.192204B | -46.41% | 192.2M |
FQ3 2021 (Jul 2021) | 0.16 | 0.16 | 0.196659B | 3.8% | 196.66M |
FQ2 2021 (Apr 2021) | -0.02 | -0.02 | 0.164698B | -55.08% | 164.7M |
FQ1 2021 (Jan 2021) | -0.06 | -0.06 | 0.130434B | -17.47% | 130.43M |
FQ4 2020 (Oct 2020) | 0.000441468 | 0.000441468 | 0.281411B | 100% | 281.41M |
FQ3 2020 (Jul 2020) | 0.05 | 0.05 | 0.189181B | -81.59% | 189.18M |
FQ4 Announce Date
06/29/2024 (Pre-Market)
Consensus EPS Estimates
0.43429
Consensus Revenue Estimates
0.317373435B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2026 (Jun 2026) | -0.6286 | -- | -0.64316 | -0.61145 | 0 |
FQ1 2026 (Mar 2026) | -0.5374 | -- | -0.54985 | -0.52273 | 0 |
FQ4 2025 (Dec 2025) | -0.6648 | -- | -0.6802 | -0.64666 | 2 |
FQ3 2025 (Sep 2025) | 0.73667 | -- | 0.70477 | 0.76275 | 2 |
FQ2 2025 (Jun 2025) | 0.68 | -- | 0.65055 | 0.70407 | 2 |
FQ1 2025 (Mar 2025) | 0.55667 | -- | 0.53256 | 0.57637 | 2 |
FQ4 2024 (Dec 2024) | 0.50333 | -- | 0.48153 | 0.52115 | 0 |
FQ3 2024 (Jul 2024) | 1.34259 | -- | 1.1469 | 1.53828 | 3 |
FQ2 2024 (Jun 2024) | 0.43429 | -- | 0.41548 | 0.44966 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2026 (Jun 2026) | 0.4B | -- | 0.39B | 0.4B | 1 |
FQ1 2026 (Mar 2026) | 0.33B | -- | 0.32B | 0.34B | 1 |
FQ4 2025 (Dec 2025) | 0.32B | -- | 0.31B | 0.32B | 1 |
FQ3 2025 (Sep 2025) | 0.38B | -- | 0.37B | 0.39B | 1 |
FQ2 2025 (Jun 2025) | 0.37B | -- | 0.35B | 0.38B | 1 |
FQ1 2025 (Mar 2025) | 0.33B | -- | 0.32B | 0.34B | 1 |
FQ4 2024 (Dec 2024) | 0.32B | -- | 0.31B | 0.33B | 1 |
FQ3 2024 (Jul 2024) | 0.59B | -- | 0.52B | 0.65B | 13 |
FQ2 2024 (Jun 2024) | 0.32B | -- | 0.31B | 0.33B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | -0.38 | -0.38 | 100% | |
FQ1 2022 (Jan 2022) | -0.15 | -0.15 | 100% | |
FQ4 2021 (Oct 2021) | -0.09 | -0.09 | 100% | |
FQ3 2021 (Jul 2021) | 0.16 | 0.16 | 100% | |
FQ2 2021 (Apr 2021) | -0.02 | -0.02 | 100% | |
FQ1 2021 (Jan 2021) | -0.06 | -0.06 | 100% | |
FQ4 2020 (Oct 2020) | 0.000441468 | 0.000441468 | 100% | |
FQ3 2020 (Jul 2020) | 0.05 | 0.05 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | $0B | $0.21B | $207.66M | 100% |
FQ1 2022 (Jan 2022) | $0B | $0.13B | $129.22M | 100% |
FQ4 2021 (Oct 2021) | $0B | $0.19B | $192.2M | 100% |
FQ3 2021 (Jul 2021) | $0B | $0.2B | $196.66M | 100% |
FQ2 2021 (Apr 2021) | $0B | $0.16B | $164.7M | 100% |
FQ1 2021 (Jan 2021) | $0B | $0.13B | $130.43M | 100% |
FQ4 2020 (Oct 2020) | $0B | $0.28B | $281.41M | 100% |
FQ3 2020 (Jul 2020) | $0B | $0.19B | $189.18M | 100% |